Spinal Implants – Market Insights – Asia Pacific

The COVID-19 pandemic impacted the Asia Pacific spinal implant market in the short term, slowing growth due to deferral of elective procedures accompanied by supply chain issues and pricing pressures. Beyond the COVID-19 pandemic, the Asia Pacific spinal implant market experienced particularly strong growth in 2021 as deferred procedures were rescheduled. The market will continue to experience strong growth throughout the forecast period. Although the crisis has significantly impacted the market in the short-term, other factors will continue to drive market growth over the forecast period. In particular, spinal implant market expansion will be driven by the uptake of premium innovations such as 3-D printed implants, nonfusion technologies, and minimally invasive devices. Nonetheless, challenging reimbursement environments, and nationalist policies in China and India and implant commoditization will limit overall market potential. Going onwards in coming forecasted year, the market revenue growth might be hampered to some extent by pricing constraints, particularly in China, where a volume-based procurement initiative will expand to a wider range of orthopedic devices.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for spinal implants in the Asia Pacific region from 2019 through 2031.

The COVID-19 pandemic is having a significant impact on markets for devices used in elective procedures, including spinal implants.

How has COVID-19 affected procedure volumes in the Asia Pacific spinal implant market?

How the pandemic has impacted the market dynamics and what strategies can companies use to remain successful in this market?

When will each segment of the market return to levels seen prior to the pandemic?

Government policies in countries such as India and China will support procedure volumes in the Asia Pacific region.

How will policies such as the Ayushman Bharat Yojana impact the Indian spinal implant market?

How will these policies affect adoption of MNC and domestic manufacturer products?

What effect will the government initiatives such as China’s two-invoice policy will have on the market?

Large number of aging populations in China and India along with increase in middle classes will support market revenues throughout the forecast period.

How will growing population affect the market?

How will recent efforts to improve healthcare infrastructure in China and India affect the adoption of these procedures?

What extent will procedure volumes grow within the Chinese market for spinal implants?

Strategic acquisitions, partnerships, and distribution deals help manufacturers expand their product portfolios and customer bases.

Which competitors have recently engaged in acquisitions or partnership activities?

What are the benefits for companies partnering with or acquiring other competitors in the spinal implant market?

What strategies are smaller orthopedic manufacturers adopting to fill their portfolio gaps?

Domestic companies are offering attractive pricing to target budget-constrained facilities, particularly in China and India.

Which local competitors have been able to capture notable shares within the Asia Pacific spinal implant space?

What are the key competitive strategies that foreign MNCs and local companies must be mindful of?